View Older Stories View More Recent Stories

Jun 25, 2020 10:03AM Abbott (ABT) Announces New Late-Breaking Data Highlight Impact of its Minimally Invasive Structural Heart Therapies
Jun 25, 2020 10:00AM New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapies
Jun 24, 2020 08:30AM New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting
May 25, 2020 02:00AM Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine
May 19, 2020 04:01PM Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
May 19, 2020 04:01PM Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
May 14, 2020 01:00AM Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO
May 13, 2020 05:00PM Genentech to Present First Clinical Data on Novel Anti-TIGIT Cancer Immunotherapy Tiragolumab at ASCO
May 5, 2020 11:00AM sticky.io Announces Growth Equity Investment Following Recent Rebrand
Apr 23, 2020 08:00AM Bayer to Highlight Clinical Data on Vitrakvi® (larotrectinib) and Research on Investigational AhR Inhibitor at AACR 2020 Virtual Meeting
Apr 15, 2020 09:00AM VIDA Completes Second Close Of Round C Financing
Mar 26, 2020 01:00PM Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development
Mar 26, 2020 01:00PM Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development
Mar 25, 2020 01:43PM Independent Third-Party Analyst Gives UC Asset “Buy” Rating with Target Price at $5.50 per Share
Mar 17, 2020 11:00AM World's First Analysis of Collaboration Platform Microsoft Teams Released by SWOOP Analytics
Mar 12, 2020 10:00AM VIDA Announces Series C Financing To Accelerate Access To AI-Powered Lung Imaging Analysis
Mar 10, 2020 10:00AM Amid Coronavirus Outbreak, New Research Reveals the Makeup of the U.S. State and Local Public Health Workforce
Feb 26, 2020 07:00AM Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities
Feb 25, 2020 04:06PM Exelixis Announces First 100 Patients Enrolled in Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Relapsed Radioiodine-Refractory Differentiated Thyroid Cancer
Feb 14, 2020 06:01AM UPDATE: First Analysis Downgrades CryoLife (CRY) to Outperform
Feb 12, 2020 07:20PM First Analysis Upgrades CyberArk Software (CYBR) to Strong Buy
Jan 14, 2020 04:22PM First Analysis Starts Zuora Inc. (ZUO) at Outperform
Jan 12, 2020 02:00PM Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area
Jan 10, 2020 06:22AM First Analysis Upgrades Anika Therapeutics (ANIk) to Strong Buy
Jan 6, 2020 10:31AM Premier Inc. Analysis: Complications & Common Chronic Conditions Increase Hospitals’ Childbirth Costs by 20 Percent or More
Dec 20, 2019 06:05AM First Analysis Downgrades CalAmp Corp. (CAMP) to Neutral
Dec 10, 2019 09:19AM Pre-Open Movers 12/10: (ASNA) (GNW) (SFIX) Higher; (CONN) (SCYX) (FRAN) Lower (more...)
Dec 10, 2019 07:29AM First Analysis Upgrades Avid Bioservices (CDMO) to Strong Buy
Dec 4, 2019 10:35AM First Analysis Downgrades Instructure, Inc. (INST) to Neutral Following Acquisition
Dec 4, 2019 07:01AM AVEO Oncology (AVEO) Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in RCC
Dec 4, 2019 07:00AM AVEO Oncology Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma
Dec 2, 2019 08:00PM Astellas Presents New Data on XOSPATA® (gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting
Nov 27, 2019 04:18AM The Global Beauty Community Gathers at Cosmoprof Asia 2019
Nov 21, 2019 08:34AM AbbVie (ABBV) to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at ASH
Nov 21, 2019 08:30AM AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting
Nov 18, 2019 06:05AM AVEO Oncology (AVEO) Highlights Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in RCC
Nov 18, 2019 06:00AM AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma
Nov 12, 2019 04:26PM First Analysis Starts Smartsheet Inc. (SMAR) at Outperform
Nov 8, 2019 08:02AM PathAI and Gilead Show AI-Powered Pathology Research Models Accurately Interpret Liver Histology in Patients with NASH at AASLD 2019
Nov 7, 2019 06:45AM First Analysis Upgrades Quotient Technology (QUOT) to Strong Buy
Nov 6, 2019 05:28PM Takeda's (TAK) Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
Nov 6, 2019 05:00PM Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
Nov 6, 2019 07:00AM Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results
Nov 5, 2019 08:50AM Octapharma’s fibryga® Receives European Label Extension to Treat Acquired Fibrinogen Deficiency (AFD)
Nov 1, 2019 08:12AM First Analysis Upgrades Repligen (RGEN) to Strong Buy
Oct 31, 2019 04:19PM First Analysis Starts Upwork Inc. (UPWK) at Outperform
Oct 25, 2019 06:52AM First Analysis Upgrades SPS Commerce (SPSC) to Strong Buy
Oct 24, 2019 06:12AM First Analysis Downgrades LeMaitre Vascular (LMAT) to Outperform
Oct 21, 2019 05:20AM First Analysis Upgrades Alarm.com (ALRM) to Strong Buy
Oct 14, 2019 04:54AM First Analysis Upgrades LeMaitre Vascular (LMAT) to Strong Buy
View More Recent Stories View Older Stories